This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. BMJ Authors Challenge Pharma’s Concerns About ‘Innovation Crisis’ MinnPost: Big Pharma’s Claim Of An ‘Innovation Crisis’ Is A Myth, BMJ Authors SayFor the past decade or so, we’ve been hearing repeatedly about an “innovation” crisis in pharmaceuticals. Big Pharma and its friends in government and elsewhere have claimed that research into new drugs is slowing down, primarily, they say, because of onerous regulatory demands … But is it true? Is there really an innovation crisis? No, according to a new analysis published Tuesday on BMJ.com. The real crisis is in a system that rewards drug companies for developing new products that offer few, if any, therapeutic benefits over existing ones (Perry, 8/8).